{"hands_on_practices": [{"introduction": "The first step in analyzing any Ames test is to visually inspect the data for key patterns, which is essential for designing a robust quantitative analysis. This practice focuses on identifying the hallmark of a mutagenic response—a dose-dependent increase in revertant colonies—and distinguishing it from the confounding effect of cytotoxicity, where high compound concentrations can kill the bacteria and artificially lower the colony count. Mastering this interpretative skill allows you to quickly assess experimental outcomes and avoid common errors, such as concluding a compound is non-mutagenic when its effect is simply masked by toxicity [@problem_id:2096140].", "problem": "A microbiologist is performing an Ames test to evaluate the mutagenic potential of two new chemical compounds, Alpha and Beta. The test uses a specially engineered strain of *Salmonella enterica* serovar Typhimurium that is a histidine-auxotroph (his-), meaning it cannot synthesize the amino acid histidine and requires it in the growth medium to survive. The assay measures the frequency of back-mutation (reversion) from the his- state to a prototrophic his+ state, which allows the bacteria to grow on a minimal agar medium that lacks histidine.\n\nThe researcher prepares a series of plates. Each plate contains the minimal medium, a lawn of the his- *Salmonella* strain, and a specific test substance. The only source of histidine is a trace amount added to the medium to permit a few rounds of cell division, which is necessary for mutagenesis to occur. After a 48-hour incubation period, the number of visible bacterial colonies (revertants) on each plate is counted.\n\nThe experimental setup and results are as follows:\n\n*   **Plate 1 (Negative Control):** Contains the bacteria and the solvent used to dissolve the compounds (sterile water).\n    *   Result: 22 colonies\n*   **Plate 2 (Positive Control):** Contains the bacteria and a known potent mutagen.\n    *   Result: 610 colonies\n*   **Plate 3:** Contains the bacteria and 5 micrograms of Compound Alpha.\n    *   Result: 185 colonies\n*   **Plate 4:** Contains the bacteria and 50 micrograms of Compound Alpha.\n    *   Result: 750 colonies\n*   **Plate 5:** Contains the bacteria and 5 micrograms of Compound Beta.\n    *   Result: 215 colonies\n*   **Plate 6:** Contains the bacteria and 50 micrograms of Compound Beta.\n    *   Result: 8 colonies\n\nBased on this complete set of data, what is the most scientifically sound conclusion regarding the properties of Compound Beta?\n\nA. Compound Beta is mutagenic at low concentrations, but this effect is masked at high concentrations due to the compound's toxicity to the bacteria.\n\nB. Compound Beta is mutagenic only at a concentration of 5 micrograms and is definitively not mutagenic at 50 micrograms.\n\nC. The results for Compound Beta are inconclusive due to a likely experimental error, such as the failure to add the compound to Plate 6.\n\nD. Compound Beta becomes an anti-mutagen at high concentrations, actively preventing both induced and spontaneous mutations.\n\nE. The *Salmonella* strain used in the experiment developed a rapid resistance to the mutagenic effects of Compound Beta at high concentrations.", "solution": "1) State the governing principle of the Ames test. The assay measures mutagenicity by comparing the number of his+ revertant colonies induced by a test compound to the spontaneous reversion baseline measured in a negative control. Therefore:\n- If the revertant count with a compound is significantly greater than the negative control, the compound is mutagenic at that dose.\n- If the revertant count is much lower than the negative control, this typically indicates cytotoxicity (killing/inhibition of bacteria), which can mask mutagenicity.\n- A valid positive control must yield a high revertant count to confirm assay sensitivity.\n\n2) Verify that assay controls behave as expected. The negative control yields $22$ colonies (spontaneous revertants). The positive control yields $610$ colonies, which is far above $22$, confirming the assay can detect mutagenicity and that the bacterial lawn and conditions are suitable.\n\n3) Use the data pattern to interpret the effect of Compound Beta. For Compound Beta:\n- At $5$ micrograms, there are $215$ colonies, which is markedly greater than the negative control $22$. By the Ames test criterion, this indicates mutagenicity at the low dose.\n- At $50$ micrograms, there are $8$ colonies, which is lower than the negative control $22$. Such a reduction below the spontaneous baseline is characteristic of cytotoxicity (fewer viable bacteria capable of undergoing reversion), not of a simple absence of mutagenicity. In Ames assays, high-dose cytotoxicity commonly reduces revertant counts and can mask an underlying mutagenic effect.\n\n4) Evaluate the alternative explanations against Ames test principles and the data:\n- Option A (mutagenic at low dose; high-dose toxicity masks effect) matches the observed increase at $5$ micrograms ($215 \\gg 22$) and the drop below baseline at $50$ micrograms ($8 < 22$), a classic sign of cytotoxicity at high concentration.\n- Option B (mutagenic only at $5$ micrograms and definitively not mutagenic at $50$ micrograms) is not justified because cytotoxicity at high dose prevents concluding non-mutagenicity; low colony counts at high dose are confounded by toxicity.\n- Option C (inconclusive due to likely experimental error on Plate 6) is not the most parsimonious explanation; the pattern is exactly what is expected when a compound is mutagenic at low dose and toxic at high dose. No control suggests a procedural failure.\n- Option D (becomes an anti-mutagen at high concentrations) is not supported; an anti-mutagen reduces mutation frequency when co-present with a mutagen. Here, the compound alone at high dose lowers colonies below the spontaneous baseline, indicating cytotoxicity rather than active anti-mutagenic activity.\n- Option E (rapid resistance to mutagenic effects at high dose) is biologically implausible in this context and would not explain a revertant count below the negative control.\n\n5) Conclusion. The most scientifically sound interpretation is that Compound Beta is mutagenic at low concentration, while high concentration is cytotoxic, masking mutagenicity. Therefore, the correct choice is A.", "answer": "$$\\boxed{A}$$", "id": "2096140"}, {"introduction": "After a qualitative assessment, the next step is to derive a quantitative measure of mutagenic strength, typically the \"mutagenic potency\" from the initial linear portion of the dose-response curve. This exercise provides a hands-on opportunity to process raw Ames test data by calculating background-corrected revertant counts and performing a linear regression to find the slope. By completing this practice, you will learn the standard procedure for transforming raw colony counts into a scientifically meaningful and comparable metric of mutagenicity, a fundamental skill in genetic toxicology [@problem_id:2513849].", "problem": "An investigator is quantifying mutagenic potency in the Ames test using Salmonella enterica serovar Typhimurium strain TA100 without rat liver post-mitochondrial fraction (S9). The compound is plated at several doses in triplicate on minimal agar with histidine limitation and the number of revertant colonies per plate is counted after incubation. The foundational facts to use are: (i) reversion to prototrophy requires DNA sequence changes; (ii) at low doses where cytotoxicity is negligible, the expected number of induced revertants is approximately proportional to the applied dose; (iii) spontaneous revertants occur at zero dose and must be accounted for as background; (iv) counts of rare, independent events are well described by Poisson statistics; and (v) the initial slope of the background-corrected dose–response is a measure of mutagenic potency with units of revertants per plate per dose unit. The data below were obtained under a single condition (TA100, no S9, one experiment, triplicate plates per dose). Doses are in $\\mu\\text{g}$/plate.\n\n- Dose $0$: plate counts $18$, $22$, $20$.\n- Dose $0.05$: plate counts $26$, $28$, $29$.\n- Dose $0.10$: plate counts $34$, $35$, $37$.\n- Dose $0.20$: plate counts $52$, $48$, $49$.\n- Dose $0.50$: plate counts $96$, $93$, $98$.\n- Dose $1.50$: plate counts $180$, $170$, $160$.\n\nAssuming the low-dose region is linear up to and including $0.50$ $\\mu\\text{g}$/plate and that background (spontaneous) counts must be subtracted before modeling induced revertants, which option correctly reports the numerical slope of revertants per plate per $\\mu\\text{g}$ from the linear portion and interprets this slope as a mutagenic potency metric under the stated conditions?\n\nA. After subtracting the spontaneous mean at dose $0$ and regressing net revertants on dose over $0.05$–$0.50$ $\\mu\\text{g}$/plate with the intercept constrained to $0$, the slope is approximately $151$ revertants per plate per $\\mu\\text{g}$. This slope is the mutagenic potency for this strain and condition (TA100, no S9).\n\nB. Including all doses up to $1.50$ $\\mu\\text{g}$/plate and allowing a free intercept yields a slope of approximately $120$ revertants per plate per $\\mu\\text{g}$. Because high-dose cytotoxicity reduces counts, this underestimates potency, but the resulting slope is nevertheless the correct potency metric.\n\nC. If background is not subtracted and the fit is forced through the origin over $0.05$–$0.50$ $\\mu\\text{g}$/plate, the slope is approximately $207$ revertants per plate per $\\mu\\text{g}$, which correctly characterizes the compound’s mutagenic potency.\n\nD. After subtracting background and fitting a line over $0.05$–$0.50$ $\\mu\\text{g}$/plate with a free intercept, the slope is approximately $155$ revertants per plate per $\\mu\\text{g}$ and the intercept is approximately $+7$ revertants per plate; the mutagenic potency is given by this positive intercept.", "solution": "The problem statement poses a quantitative analysis of data from a bacterial reverse mutation assay, commonly known as the Ames test. The task is to determine the mutagenic potency of a compound under specified conditions.\n\n**Step 1: Validation of the Problem Statement**\n\nFirst, I shall ascertain the validity of the problem.\n\nExtracted Givens:\n- Test System: *Salmonella enterica* serovar Typhimurium strain TA100, without S9 metabolic activation.\n- Assay: Triplicate plates per dose on minimal agar with limited histidine.\n- Data Acquired: Revertant colonies per plate.\n- Foundational Facts:\n    (i) Reversion is due to DNA sequence changes.\n    (ii) Induced revertants are proportional to dose in the low-dose, non-cytotoxic region.\n    (iii) Spontaneous revertants (background) at zero dose exist and must be subtracted.\n    (iv) Colony counts follow Poisson statistics.\n    (v) Mutagenic potency is defined as the initial slope of the background-corrected dose–response curve (units: revertants/plate per dose unit).\n- Data (Dose in $\\mu\\text{g}$/plate):\n    - Dose $0$: $18, 22, 20$ colonies.\n    - Dose $0.05$: $26, 28, 29$ colonies.\n    - Dose $0.10$: $34, 35, 37$ colonies.\n    - Dose $0.20$: $52, 48, 49$ colonies.\n    - Dose $0.50$: $96, 93, 98$ colonies.\n    - Dose $1.50$: $180, 170, 160$ colonies.\n- Assumptions for Analysis:\n    - The low-dose region is linear up to and including the $0.50$ $\\mu\\text{g}$/plate dose.\n    - Background counts must be subtracted before modeling.\n\nValidation Using Extracted Givens:\nThe problem is scientifically grounded, describing a standard Ames test protocol. The provided foundational facts (i-v) are correct principles for the analysis of such data. The problem is well-posed, providing sufficient numerical data and explicit instructions for calculating a unique result. The language is objective and unambiguous. It does not violate any criteria for invalidity. The data points are realistic for this type of experiment.\n\nVerdict: The problem statement is valid.\n\n**Step 2: Derivation of the Solution**\n\nThe objective is to calculate the slope of the linear portion of the background-corrected dose-response curve.\n\nFirst, calculate the mean number of spontaneous revertants from the zero-dose control plates. This represents the background.\nLet $\\bar{N}_{sp}$ be the mean spontaneous revertant count.\n$$ \\bar{N}_{sp} = \\frac{18 + 22 + 20}{3} = \\frac{60}{3} = 20 \\text{ revertants/plate} $$\n\nAccording to the problem, background must be subtracted to find the number of induced revertants. The model for induced revertants, $I$, as a function of dose, $D$, is stated to be linear at low doses: $I = m \\cdot D$. This relationship implies that at $D=0$, the number of induced revertants must be $I=0$. Therefore, a linear regression of induced revertants versus dose must be constrained to pass through the origin (zero intercept).\n\nThe analysis is restricted to the linear region, which includes doses up to $0.50$ $\\mu\\text{g}$/plate. We will use all individual plate counts within this range, correct them for background, and then perform a linear regression through the origin. The data points for the regression, $(D_k, I_k)$, are derived by subtracting the mean spontaneous count, $\\bar{N}_{sp} = 20$, from each plate count, $N_k$, at doses greater than zero.\n\nThe data for regression are as follows ($I_k = N_k - 20$):\n- For $D = 0.05 \\mu\\text{g}$/plate: $I_k = 26-20=6, 28-20=8, 29-20=9$.\n- For $D = 0.10 \\mu\\text{g}$/plate: $I_k = 34-20=14, 35-20=15, 37-20=17$.\n- For $D = 0.20 \\mu\\text{g}$/plate: $I_k = 52-20=32, 48-20=28, 49-20=29$.\n- For $D = 0.50 \\mu\\text{g}$/plate: $I_k = 96-20=76, 93-20=73, 98-20=78$.\n\nWe have a set of $n=12$ data points $(D_k, I_k)$. The slope $m$ for a simple linear regression model $I = mD$ (forced through the origin) is given by the formula:\n$$ m = \\frac{\\sum_{k=1}^{n} D_k I_k}{\\sum_{k=1}^{n} D_k^2} $$\n\nFirst, calculate the denominator, $\\sum D_k^2$:\n$$ \\sum D_k^2 = 3 \\times (0.05)^2 + 3 \\times (0.10)^2 + 3 \\times (0.20)^2 + 3 \\times (0.50)^2 $$\n$$ \\sum D_k^2 = 3 \\times (0.0025 + 0.01 + 0.04 + 0.25) = 3 \\times 0.3025 = 0.9075 $$\n\nNext, calculate the numerator, $\\sum D_k I_k$:\n$$ \\sum D_k I_k = 0.05(6+8+9) + 0.10(14+15+17) + 0.20(32+28+29) + 0.50(76+73+78) $$\n$$ \\sum D_k I_k = 0.05(23) + 0.10(46) + 0.20(89) + 0.50(227) $$\n$$ \\sum D_k I_k = 1.15 + 4.6 + 17.8 + 113.5 = 137.05 $$\n\nNow, calculate the slope, $m$:\n$$ m = \\frac{137.05}{0.9075} \\approx 151.019... \\text{ revertants per plate per } \\mu\\text{g} $$\nThis slope represents the mutagenic potency as defined in foundational fact (v).\n\n**Step 3: Option-by-Option Analysis**\n\nA. After subtracting the spontaneous mean at dose $0$ and regressing net revertants on dose over $0.05$–$0.50$ $\\mu\\text{g}$/plate with the intercept constrained to $0$, the slope is approximately $151$ revertants per plate per $\\mu\\text{g}$. This slope is the mutagenic potency for this strain and condition (TA100, no S9).\n- This option describes the exact procedure dictated by the problem statement and established scientific practice. The procedure involves background subtraction, use of the specified linear dose range, and fitting a model for induced mutation which must be zero at zero dose (i.e., regression through the origin). My calculation confirms the slope is approximately $151$. The interpretation of this slope as mutagenic potency is correct per foundational fact (v).\n- **Verdict: Correct.**\n\nB. Including all doses up to $1.50$ $\\mu\\text{g}$/plate and allowing a free intercept yields a slope of approximately $120$ revertants per plate per $\\mu\\text{g}$. Because high-dose cytotoxicity reduces counts, this underestimates potency, but the resulting slope is nevertheless the correct potency metric.\n- This option is incorrect for multiple reasons. First, it violates the directive to use the linear region up to $0.50$ $\\mu\\text{g}$/plate. Potency is defined by the *initial* slope, and including higher doses where effects like saturation or cytotoxicity may occur will distort this estimate. Second, after background subtraction, the theoretical model for induced revertants has a zero intercept, so allowing a free intercept is inappropriate for estimating the potency parameter. Third, it incorrectly claims the resulting underestimated slope is the correct potency metric.\n- **Verdict: Incorrect.**\n\nC. If background is not subtracted and the fit is forced through the origin over $0.05$–$0.50$ $\\mu\\text{g}$/plate, the slope is approximately $207$ revertants per plate per $\\mu\\text{g}$, which correctly characterizes the compound’s mutagenic potency.\n- This procedure is fundamentally flawed. It violates the explicit instruction to subtract background. The model for total revertants ($N_{total} = mD + N_{sp}$) has a non-zero intercept equal to the spontaneous background count. Forcing a regression on total counts through the origin is a severe model misspecification that artificially inflates the slope. The resulting value does not represent the mutagenic potency, which relates dose to *induced* revertants. My calculation confirms the numerical value of $207$ is obtained via this flawed method, but the method itself is invalid.\n- **Verdict: Incorrect.**\n\nD. After subtracting background and fitting a line over $0.05$–$0.50$ $\\mu\\text{g}$/plate with a free intercept, the slope is approximately $155$ revertants per plate per $\\mu\\text{g}$ and the intercept is approximately $+7$ revertants per plate; the mutagenic potency is given by this positive intercept.\n- This option contains multiple errors. First, the primary definition of mutagenic potency is the slope, not the intercept. The statement \"the mutagenic potency is given by this positive intercept\" is a misunderstanding of the concept. Potency has units of revertants/dose, which corresponds to the slope. Second, while a linear regression with a free intercept on background-subtracted data gives a slope of approximately $155$ and an intercept of approximately $-1.3$ (close to the theoretical $0$), the value of $+7$ for the intercept is not supported by the data and is physically meaningless. The entire interpretation is wrong.\n- **Verdict: Incorrect.**\n\nBased on a rigorous application of the principles and instructions provided, only option A is correct in its methodology, calculation, and interpretation.", "answer": "$$\\boxed{A}$$", "id": "2513849"}, {"introduction": "A fitted statistical model is a powerful tool for prediction and for quantifying the confidence in your conclusions. This practice challenges you to work backwards from a given linear model to determine the specific dose required to elicit a certain level of mutagenic response. Critically, it requires you to apply the principles of first-order uncertainty propagation to calculate the standard error of this dose estimate, honing your ability to report findings with appropriate statistical rigor [@problem_id:2513959].", "problem": "In the *Salmonella enterica* serovar Typhimurium histidine reversion mutagenicity assay (the Ames test), the expected number of revertant colonies per plate, denoted by $y$, is modeled as a linear function of the applied dose $d$ (in $\\mu g$ per plate) in the low-dose regime: $y = \\beta_{0} + \\beta_{1} d$. Here $\\beta_{0}$ represents the expected background revertants in solvent control plates and $\\beta_{1}$ represents the slope of the dose-response in units of revertants per $\\mu g$. Suppose a series of dose plates, with and without metabolic activation, yields a fitted linear model with $\\beta_{1} = 15$ revertants per $\\mu g$ and $\\beta_{0} = 25$ revertants per plate. The standard error of the slope estimate is $\\operatorname{SE}(\\beta_{1}) = 1.1$ revertants per $\\mu g$. Using only fundamental definitions of the linear dose-response, the notion of “extra” revertants above background, and first-order uncertainty propagation, determine:\n- the dose $d^{\\ast}$ that produces an extra $100$ revertants per plate above background, and\n- the standard error $\\operatorname{SE}(d^{\\ast})$ of this dose estimate, treating $\\beta_{1}$ as the only uncertain parameter.\n\nExpress $d^{\\ast}$ and $\\operatorname{SE}(d^{\\ast})$ in $\\mu g$ per plate. Round both to three significant figures.", "solution": "The problem will first be subjected to a rigorous validation procedure.\n\n**Problem Validation**\n\n**Step 1: Extract Givens**\nThe problem provides the following information:\n- The linear dose-response model: $y = \\beta_{0} + \\beta_{1} d$.\n- $y$: expected number of revertant colonies per plate.\n- $d$: applied dose in $\\mu g$ per plate.\n- $\\beta_{0}$: expected background revertants.\n- $\\beta_{1}$: slope of the dose-response in revertants per $\\mu g$.\n- Fitted value for the intercept: $\\beta_{0} = 25$ revertants per plate.\n- Fitted value for the slope: $\\beta_{1} = 15$ revertants per $\\mu g$.\n- Standard error of the slope estimate: $\\operatorname{SE}(\\beta_{1}) = 1.1$ revertants per $\\mu g$.\n- Objective $1$: Find the dose $d^{\\ast}$ that produces an extra $100$ revertants per plate above background.\n- Objective $2$: Find the standard error of this dose estimate, $\\operatorname{SE}(d^{\\ast})$.\n- Constraint: Treat $\\beta_{1}$ as the only uncertain parameter.\n- Final formatting: Round results to three significant figures.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is assessed against the criteria for validity.\n\n- **Scientifically Grounded**: The problem is based on the Ames test, a standard, widely-used mutagenicity assay in microbiology and toxicology. The use of a linear model for the low-dose region of a dose-response curve is a common and accepted practice. The statistical concepts of parameter estimation (slope $\\beta_1$) and its uncertainty ($\\operatorname{SE}(\\beta_1)$) are fundamental to experimental data analysis. The problem is scientifically and factually sound.\n- **Well-Posed**: All necessary numerical values and a clear model are provided to calculate the requested quantities. The instruction to treat only $\\beta_{1}$ as uncertain is a simplifying assumption, but it makes the problem well-defined and solvable. A unique solution exists.\n- **Objective**: The problem is stated in precise, quantitative terms, free from ambiguity or subjective content.\n\nThe problem does not exhibit any flaws such as scientific unsoundness, incompleteness, or ambiguity. It is a standard problem in biostatistics and quantitative toxicology.\n\n**Step 3: Verdict and Action**\nThe problem is deemed **valid**. A solution will be derived.\n\n**Derivation of Solution**\n\nThe analysis proceeds by addressing the two objectives in sequence.\n\nFirst, we determine the dose $d^{\\ast}$ that yields a specified number of \"extra\" revertants. The linear model for the total number of revertants $y$ at a dose $d$ is given by:\n$$y(d) = \\beta_{0} + \\beta_{1} d$$\nThe number of background revertants corresponds to the dose $d=0$, which is $y(0) = \\beta_{0}$. The \"extra\" revertants, which we denote as $y_{extra}$, are the number of revertants induced by the chemical dose above this background level. This is given by:\n$$y_{extra}(d) = y(d) - y(0) = (\\beta_{0} + \\beta_{1} d) - \\beta_{0} = \\beta_{1} d$$\nWe are required to find the dose $d^{\\ast}$ for which the number of extra revertants is $100$. We set $y_{extra}(d^{\\ast}) = 100$:\n$$100 = \\beta_{1} d^{\\ast}$$\nSolving for $d^{\\ast}$ gives the expression:\n$$d^{\\ast} = \\frac{100}{\\beta_{1}}$$\nUsing the provided value for the slope, $\\beta_{1} = 15$ revertants per $\\mu g$:\n$$d^{\\ast} = \\frac{100}{15} = \\frac{20}{3} \\approx 6.666...$$\nRounding to three significant figures as required, we obtain:\n$$d^{\\ast} \\approx 6.67 \\, \\mu g$$\n\nSecond, we determine the standard error of this dose estimate, $\\operatorname{SE}(d^{\\ast})$. The problem specifies to use first-order uncertainty propagation and to treat $\\beta_{1}$ as the only source of uncertainty. The quantity $d^{\\ast}$ is a function of the random variable $\\beta_{1}$. For a general function $f(x)$, the first-order approximation for the propagation of variance is:\n$$(\\operatorname{SE}(f(x)))^{2} \\approx \\left( \\frac{df}{dx} \\right)^{2} (\\operatorname{SE}(x))^{2}$$\nTaking the square root, we find the standard error:\n$$\\operatorname{SE}(f(x)) \\approx \\left| \\frac{df}{dx} \\right| \\operatorname{SE}(x)$$\nIn our specific case, the function is $d^{\\ast}(\\beta_{1}) = \\frac{100}{\\beta_{1}}$ and the variable is $\\beta_{1}$. We must first compute the derivative of $d^{\\ast}$ with respect to $\\beta_{1}$:\n$$\\frac{d}{d\\beta_{1}} d^{\\ast}(\\beta_{1}) = \\frac{d}{d\\beta_{1}} \\left( \\frac{100}{\\beta_{1}} \\right) = \\frac{d}{d\\beta_{1}} (100 \\beta_{1}^{-1}) = -100 \\beta_{1}^{-2} = -\\frac{100}{\\beta_{1}^{2}}$$\nThe standard error of $d^{\\ast}$ is therefore approximated as:\n$$\\operatorname{SE}(d^{\\ast}) \\approx \\left| -\\frac{100}{\\beta_{1}^{2}} \\right| \\operatorname{SE}(\\beta_{1}) = \\frac{100}{\\beta_{1}^{2}} \\operatorname{SE}(\\beta_{1})$$\nWe are given the values $\\beta_{1} = 15$ and $\\operatorname{SE}(\\beta_{1}) = 1.1$. Substituting these into the expression:\n$$\\operatorname{SE}(d^{\\ast}) \\approx \\frac{100}{(15)^{2}} \\times 1.1 = \\frac{100}{225} \\times 1.1 = \\frac{4}{9} \\times 1.1$$\nNow, we compute the numerical value:\n$$\\operatorname{SE}(d^{\\ast}) \\approx 0.444... \\times 1.1 = 0.4888...$$\nRounding this result to three significant figures, we obtain:\n$$\\operatorname{SE}(d^{\\ast}) \\approx 0.489 \\, \\mu g$$\n\nThe two required quantities, rounded to three significant figures, are the dose $d^{\\ast} \\approx 6.67 \\, \\mu g$ and its standard error $\\operatorname{SE}(d^{\\ast}) \\approx 0.489 \\, \\mu g$.", "answer": "$$\n\\boxed{\\begin{pmatrix} 6.67 & 0.489 \\end{pmatrix}}\n$$", "id": "2513959"}]}